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In order to control and eradicate epidemic cholera, we need to understand how epidemics
begin, how they spread, and how they decline and eventually end. This requires extensive
sampling of epidemic disease over time, alongside the background of endemic disease that
may exist concurrently with the epidemic. The unique circumstances surrounding the
Argentinian cholera epidemic of 1992–1998 presented an opportunity to do this. Here, we use
490 Argentinian V. cholerae genome sequences to characterise the variation within, and
between, epidemic and endemic V. cholerae. We show that, during the 1992–1998 cholera
epidemic, the invariant epidemic clone co-existed alongside highly diverse members of the
Vibrio cholerae species in Argentina, and we contrast the clonality of epidemic V. cholerae with
the background diversity of local endemic bacteria. Our findings refine and add nuance to our
genomic definitions of epidemic and endemic cholera, and are of direct relevance to con-
trolling current and future cholera epidemics.
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Latin America stands apart from the rest of the world interms of its history of large-scale cholera epidemics1–3.There have been seven global cholera pandemics in recorded
history, between 1819 and the present day4. Of these, the second
pandemic (1829–1850) was the first to be seen in Latin Amer-
ica5,6. Between the 1830s and 1895, the region suffered from
repeated cholera outbreaks, linked to global pandemics 2
through 5 (refs. 4,6). Importantly, although the sixth pandemic
(1899–1923)4 affected most of Africa and Asia, Latin America did
not experience cholera epidemics during this period, and thus was
free of epidemic cholera for 96 years6. In 1991, during the seventh
pandemic (1961–present), cholera returned to Latin America.
Phylogeographic data have shown that this was attributable to the
simultaneous introduction of two distinct sub-lineages of a
globally-circulating phylogenetic lineage of Vibrio cholerae ser-
ogroup O1 biotype El Tor, dubbed 7PET7–9. An antimicrobial-
sensitive sub-lineage of 7PET (LAT-1) was introduced into Peru
in January 1991 and spread rapidly across South America7,10,11.
Concurrently, a separate and distinct drug-resistant 7PET sub-
lineage (LAT-2) was introduced into Mexico1,7. The Haitian
cholera epidemic in 2010 was also caused by 7PET, albeit by a
third, independently-introduced sub-lineage, LAT-3 (refs. 7,8,12).
Since Latin America had been free of cholera epidemics for 96
years, and because the major epidemics seen in the 1990s and in
2010 are attributed to the introduction of epidemic 7PET sub-
lineages originating in South Asia7, Latin America presented a
unique opportunity to understand the longitudinal evolution of
pandemic V. cholerae upon its introduction into a naïve popula-
tion. Argentina is an ideal setting in which to study the evolution
of the pandemic clone during the 1990s because, unlike some other
countries in the region, the socioeconomic position of Argen-
tina10,13, and its preparedness for epidemics by the time cholera
reached the country, are thought to have enabled the monitoring
and control of the epidemic. Argentina instituted the mandatory
notification of cholera cases nationwide during 1991 after cholera
broke out in Peru14, and developed public information campaigns
which resulted in a concomitant increase in the rate of diarrhoeal
disease reporting15. This included changes to the Argentinian
national diarrhoeal surveillance system, and the creation of the
National Diarrhoea Network (formerly the National Cholera
Network) which comprises 75 member laboratories as of
2014 (ref. 16). In addition, cumulative numbers of cholera cases
and deaths in Argentina were reported to the World Health
Organization (WHO) and the Pan American Health Organization
(PAHO) (https://www.who.int/cholera/statistics/en/, http://ais.
paho.org/phip/viz/ed_colera_casesamericas.asp17–21, Fig. 1a).
Following the beginning of the epidemic in Peru in January 1991,
cholera spread to Argentina, with the first cholera cases reported in
Salta province18,22, near to the border with Bolivia, on the 5th of
February 1992 (refs. 11,18). Subsequently, Argentina reported cho-
lera cases annually between 1992 and 1998 (refs. 14,23–25), with a
total of 4,281 cases reported to WHO for this period17–21. Of these,
an archive of over 3,500 phenotypically-characterised V. cholerae
isolates is stored at INEI-ANLIS “Dr. Carlos G. Malbrán”, the
national reference laboratory of Argentina. From previous genomic
analyses looking across Latin America and including five Argenti-
nian isolates7,9, it is thought that a single toxigenic V. cholerae clone
belonging to the LAT-1 sub-lineage of 7PET was responsible for the
Argentinian cholera epidemics, related to that which caused out-
breaks in Peru7, and part of an epidemic which caused over 1.2
million cases of cholera across Latin America13. Therefore, we
hypothesised that studying the Argentinian epidemic would eluci-
date the progression of an epidemic attributed to one discrete
introduction of 7PET.
Given this unique set of circumstances, and that questions
remain unanswered about how epidemic 7PET V. cholerae evolves
over time after introduction to a region naïve to cholera, we
sequenced nearly 500 V. cholerae isolates from the INEI collection.
The collection is composed of all V. cholerae isolated from clinical
suspected cholera cases as defined by the Ministry of Health
between 1991 and 1998 (encompassing the epidemic period).
During this time, all suspected cholera cases were tested in
microbiology laboratories nationally, and putative V. cholerae
were isolated and sent to INEI for further confirmation. After
1999, the National Diarrhoea and Foodborne Pathogens Network
defined that one in every five stool samples should be tested for
Vibrio spp., and all resultant V. cholerae isolates should be sent to
INEI for further characterisation. The collection also includes
Vibrio spp. from various environmental surveillance programmes,
which had been collected to study the contribution of the envir-
onment to Vibrio cholerae dynamics in Argentina. Non-clinical
environmental sources are defined by INEI as food, environmental
and animal fodder; the majority of environmentally-
isolated V. cholerae were derived from water sources, including
drinking water.
We use these 490 clinical and environmental isolates and their
associated records to link epidemiological reports of epidemic
cholera in Argentina to genomic data. We also include non-O1 V.
cholerae isolates of both clinical and environmental origins, to
explore the underlying diversity of V. cholerae present in
Argentina concurrent with the 1990s cholera pandemic, and to
understand how these relate to those that caused the pandemic.
Results
Cholera outbreaks occurred annually in Argentina (1992–1997).
Between 1992 and 1998, WHO and PAHO data17 suggest that
there were two peaks of cholera incidence in Argentina, one in
1993 (2,080 cases) and one in 1996/1997 (474 and 637 cases
respectively) (Fig. 1a). However, there are discrepancies between
these apparent maxima and other reports, which have suggested
that there were seven epidemics of cholera in Argentina between
1992 and 1997 (refs. 14,23–25). To clarify this issue, we analysed the
patterns of submission date for V. cholerae isolates sent to INEI.
Between 10th February 1992 and 1st April 2002, INEI records
show that the laboratory received at least 3,631 V. cholerae sam-
ples. Sixty-nine of these isolates were recorded as coming from
countries other than Argentina: from Bolivia (n= 43), Chile (n=
16), Colombia (n= 1), Paraguay (n= 1), and Peru (n= 8). Four
isolates have no recorded origin. The remaining 3,562 isolates
originate from the North and Centre of Argentina (Fig. 1b), and
may therefore represent over 82% of the PAHO/WHO-reported
cholera cases for the whole country from this 1990s epidemic.
Following the cholera outbreak in Peru, as part of epidemic pre-
paredness, it was decided at the national level that every suspected
cholera case reported in Argentina should be tested for Vibrio
cholerae and the isolate sent to INEI from all microbiology
laboratories from the network across the country, including the
South region. V. cholerae was not reported by any of the labora-
tories from the South.
We used the metadata available for all V. cholerae samples
received between 1992 and 2002, broken down by serogroup (O1/
non-O1) and by serotype (Ogawa/Inaba). Of the isolates received,
2,189 were recorded as being of serogroup O1 (60.2%), and a total
of 1,308 non-O1 V. cholerae were recorded. The vast majority
(2,077, 94.8%) of V. cholerae O1 were of clinical origin, and 112
were either environmental isolates or their sources were not
recorded. Of the non-O1 isolates, just 714 were of clinical origin
(54.5%). From these data, it is clear that whilst there were periods
during which no V. cholerae O1 were received (Fig. 1c), non-O1
V. cholerae were submitted to INEI more consistently during
the 1990s, and their receipt rose coincidentally with peaks in
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V. cholerae O1 receipt. In addition, there were 134 isolates for
which there were no serogroup data recorded (n= 129), that were
autoagglutinable (n= 4), or were recorded as being of serogroup
O139 (n= 1).
Figure 1c illustrates at least six peaks of V. cholerae O1 receipt
within these data, occurring in early months of each year. This is
consistent with previous reports, which allude to seven seasonal
epidemics of cholera in Argentina during the 1990s14,23–25, and
likely reflects the fact that WHO/PAHO data are only available as
annual case/fatality numbers and are not broken down by month.
V. cholerae serotype Ogawa dominated the number of received V.
cholerae O1, with the exception of the incidence peak in early
1996. Ogawa isolates accounted for 1795 of all V. cholerae O1
(82.0%); 369 isolates were serotype Inaba (16.8%) (Fig. 1c). This is
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in agreement with previous reports, which indicated that
V. cholerae serotype Ogawa was predominant in Argentina
during the epidemic26, despite the initial cholera epidemic in Peru
being ascribed to V. cholerae Inaba17. Twenty-five V. cholerae O1
(1.1%) did not have a serotype assigned (Fig. 1c). The peak of V.
cholerae in January 1993 for which there were no serogroup data
recorded (n= 106; 79% of all no-data isolates) coincides with a
peak in V. cholerae O1 receipt (n= 196), and describes an
outbreak of V. cholerae O1.
These data, particularly the shifts between Inaba and Ogawa
serotype, suggested subtleties in the dynamics of cholera
epidemics in Argentina during the 1990s that could not be
understood from epidemiological data alone. We revived and
sequenced the genomes of 490 archived V. cholerae isolates from
INEI archives. These were chosen principally to capture diversity
of both O1 and non-O1 V. cholerae at the beginning (1992–1993)
and the end (1996–1997) of the Argentinian epidemic (Fig. 1d).
The sequenced isolates were a spatiotemporally-broad cross-
section of cholera incidence, from all regions of Argentina that
experienced cholera cases, and were chosen to capture apparent
shifts between Inaba and Ogawa serotype (Fig. 1c, d).
The LAT-1 sub-lineage caused pandemic cholera in Argentina.
Most of the sequenced V. cholerae isolates were found to be
members of the 7PET phylogenetic lineage (425/490, 86.7%)7.
These sequences were placed into phylogenetic context with 518
additional 7PET genomes7 (Supplementary Data 1; Fig. 2).
The vast majority of sequenced Argentinian 7PET V. cholerae
were members of LAT-1 (421/425, 99.05%), the sub-lineage
introduced into Peru in 1991 (ref. 7) (Fig. 2). No Argentinian
isolates were members of the LAT-2 sub-lineage, which was
introduced into Mexico in the early 1990s. In addition to the
LAT-1 isolates, four isolates which lacked the genes encoding the
cholera toxin (i.e. were non-toxigenic) clustered together with
F99/W, a previously-described non-toxigenic 7PET genome, also
from Formosa7,27 (Fig. 2; Supplementary Data 1; Supplementary
Figs. 1–3).
In order to obtain a LAT-1-specific phylogeny, we mapped the
reads for the genomes in this sub-lineage, as well as the direct
ancestors of LAT-1 and related genomes from Angola, Côte
d’Ivoire, and Sao Tome7,28, to a closed genome assembly of strain
A1552 (ref. 29). This Inaba V. cholerae O1 was isolated in 1992
from a Peruvian traveller29,30 and harbours the WASA-1 genomic
island, a genetic hallmark of the LAT-1 sub-lineage7,9. An
alignment of 2651 non-recombinant single nucleotide variants
(SNVs) was used to calculate a maximum-likelihood phylogeny of
these 532 genomes (Fig. 3a). We identified four genetic clusters
using Fastbaps31, which were consistent with the topology of the
phylogeny (Fig. 3a). Three clusters were specific to LAT-1
sequences from Latin America, and the fourth corresponded to
the outgroup of sequences from Angola, Côte d’Ivoire, and Sao
Tome (cluster 3, Fig. 3a).
Province-level geographic data were available for 475 of the
490 sequenced isolates, and for 416 of the 421 LAT-1 isolates
(Fig. 3a; Supplementary Fig. 4). Sequences did not cluster by
province or region. Strikingly, isolates from different Northern
provinces were interspersed amongst one another, as were isolates
from other countries in the region, such as Bolivia (Fig. 3a).
However, we did observe limited clustering by date of isolation.
Argentinian isolates from multiple provinces in 1996 and 1997
clustered phylogenetically, and isolates from 1997 occupied
cluster 1 (Fig. 3a). Similarly, cluster 2 contains Argentinian
genomes from 1992 to 1993 and one isolate from 1997, from
multiple provinces, as well as one Bolivian and one Peruvian
genome from 1992 to 1991 respectively (Fig. 3a; Supplementary
Data 2, see Microreact project linked to this paper for an
interactive map).
The LAT-1 sub-lineage has limited genetic variation. Across all
LAT-1 genomes and across the entire time period, we observed a
striking lack of variation, at the levels of SNVs, gene gain/loss,
and recombination. We found that just 0.03% of the A1552
genome was predicted to have undergone recombination (Sup-
plementary Fig. 5), and a mean of only 26.05 non-recombinant
SNVs across both chromosomes separated the sequence of each
LAT-1 isolate from that of the A1552 reference genome (Fig. 3b)
(min 10, max 149, stdev 14.10). Of the 2,651 SNVs in the LAT-1
alignment, 72.6% were private to single genomes in the data set.
This result contrasted with genomic studies of 7PET in other
settings; in hyper-endemic settings, six co-circulating sub-lineages
of 7PET could be identified over a 4-year period32; in Africa,
multiple 7PET sub-lineages have co-existed and replaced one
another since 1970 (refs. 28,33), as has been observed in
China34,35. This provided further evidence supporting the
hypothesis that the Argentinian cholera epidemic was caused by
one highly-clonal sub-lineage of 7PET.
We calculated a pangenome for LAT-1, and found that 3,368
genes were core to these isolates (present in ≥97% of isolates),
suggesting that ~89% of the 3,776 annotated genes in the A1552
reference genome are core to LAT-1. Although gene gain and loss
events were rare within LAT-1, there was evidence of the loss of
the entire CTX bacteriophage within the data set, as it was absent
from 51 of the isolates in the LAT-1 phylogeny (Fig. 3a,
Supplementary Fig. 6A). It is possible that this loss was a result of
long-term culture (some isolates were stored for 27 years before
being sequenced) as has been noted previously32,36. We did not
identify any candidate genes, which might have influenced the
rapid spread of LAT-1. Rare and sporadic gene gains were also
evident: four Argentinian LAT-1 V. cholerae carried extended-
spectrum β-lactamase (ESBL) genes, blaCTX-M-3, blaOXA-8, and
blaTEM (Fig. 3a; Supplementary Figs. 7, 8). By manual inspection
of the genome assemblies, we confirmed that these three ESBL
genes were carried on contigs that also included IncA/C plasmid
replicons (Fig. 3a; Supplementary Figs. 8, 9; Supplementary
Fig. 1 Geographic and temporal origin of Vibrio cholerae stored at INEI. Cholera cases were reported to WHO and PAHO throughout the epidemic period.
a V. cholerae O1 and non-O1 were received by INEI from the North of Argentina. b The diameter of each circle scales with the number of isolates recorded
to have originated from the indicated region. Circles are coloured by the year of receipt. Locations were inferred from the city (where recorded) or from the
province which sent the isolate to INEI. These isolates were received between 1992 and 2002. c The V. cholerae O1 received were principally clinical
isolates, whereas non-O1 V. cholerae were both clinical and environmental isolates. In our study, we sought to capture the genetic changes that occurred in
V. cholerae O1 at the beginning and the end of the cholera epidemic (d), and included contemporaneous non-O1 isolates. Geographic data were unavailable
for six O1 and 14 non-O1 V. cholerae (b); dates of isolation were not recorded for five V. cholerae (c). Four sequenced isolates had no date of isolation (d). It
should be noted that the peaks in V. cholerae receipt in 1997–1998 predate Hurricane Mitch (October 1998), a natural disaster which led to the increase of
cholera incidence in Central America94. Seven isolates from 2003 onwards that were sequenced as part of this study post-date the epidemic, and were not
included in the metadata used to produce (c). Y-axes in (c) and (d): number of isolates received/sequenced. Publicly-available data were taken from17–21,
https://www.who.int/cholera/statistics/en/, and http://ais.paho.org/phip/viz/ed_colera_casesamericas.asp, to produce (a).
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Data 2). Multidrug resistance plasmids have been seen in V.
cholerae strains from Argentina previously23,26, Algeria37, and in
Angolan isolates from 1988 and the early 1990s7,28, two of which
did harbour blaTEM (Supplementary Fig. 8; Supplementary
Data 2). However, the complement of resistance determinants
in these isolates does not match those found in Argentinian V.
cholerae (Supplementary Fig. 8, Supplementary Data 2).
Serotype variation and multiple wbeTmutations in LAT-1. The
Inaba and Ogawa serotypes of V. cholerae O1 are commonly dif-
ferentiated by diagnostic laboratories38 and by epidemiologists39 as
well as in the formulation of cholera vaccines, such as Dukoral40,
because both serotypes elicit different immunological responses41.
Methylation of the terminal perosamine sugar on the O1 lipopo-
lysaccharide chain by the WbeT enzyme confers an Ogawa phe-
notype; lack of methylation by disruption of wbeT confers an Inaba
serotype42–44. There is evidence that reversion from Inaba to Ogawa
serotype can occur in vivo, albeit rarely43,45,46.
In order to explain the apparent shifts between Inaba and
Ogawa V. cholerae seen in Argentina (Fig. 1c), and more broadly
in Latin America, we examined the sequence of wbeT in LAT-1.
We identified nine distinct mutations in wbeT across LAT-1
which were predicted to disrupt the WbeT protein by non-
synonymous, frameshift and truncating mutations (Fig. 3a;
Supplementary Fig. 7; Supplementary Data 2, see Methods for
full details). The genomic predictions correlated well with the
longitudinal data detailed in Fig. 1c and with the phenotypic
serotype assigned to each isolate; the wbeT genotype matched the
phenotypic serotype for all but two of the 398 serotyped LAT-1
isolates sequenced in this study (99.4% concordance) (Fig. 3a;
Supplementary Figs. 7, 8; Supplementary Data 2; Methods).
From previous reports, we know that the initial 1991 cholera
epidemics in Peru and elsewhere in Latin America were
associated with serotype Inaba V. cholerae, which became
dominated by serotype Ogawa bacteria in 1992 and thereafter47.
Genome sequences show that the Peruvian Inaba isolates from
1991 harbour the N165fs mutation in wbeT (Fig. 3a; Supple-
mentary Fig. 7, Supplementary Data 2). Since LAT-1 was
introduced into Latin America from West Africa7, we compared
these data to West African Inaba isolates sharing a common































Fig. 2 The vast majority of Argentinian 7PET V. cholerae O1 are members of the LAT-1 sub-lineage. A maximum-likelihood phylogeny produced for the
7PET lineage by calling SNVs between V. cholerae genome sequences and the N16961 reference genome sequence, rooted on M66, and excluding SNVs
located in potentially recombined regions of the chromosome, for a total of 7,556 SNVs. Country of origin for genomes from the Americas are reported. All
but four of the Argentinian 7PET genomes sequenced in this study are members of LAT-1 (in red). Clusters were determined using Fastbaps from an
alignment of 3,874 parsimony-informative SNVs and used to delineate the LAT-1 sub-lineage (in red). Scale bar denotes the number of mutations per
variable site.
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Angola, just after LAT-1 had been introduced into Peru7,28. These
isolates were found to harbour a different mutation, N62fs
(Fig. 3a; Supplementary Fig. 7). The N165fs mutation is present
in 68 of the genomes of LAT-1 isolates collected since 1991. These
include isolates from Brazil, Mexico, Chile, Argentina and
Colombia, as well as isolates from Peru, all of which were
originally serotyped as Inaba (Fig. 3a; Supplementary Figs. 7, 8;
Supplementary Data 2). In addition, environmental isolates from
Mexico, collected between 2004 and 2010, also harbour this
mutation and are part of the same cluster of isolates (Fig. 3a;
Supplementary Fig. 7). Hence, the N62fs and N165fs mutations
are likely to have arisen independently, prior to spreading within
West Africa and Latin America, respectively.
It has been hypothesised that cholera entered Argentina
through the North of the country, which shares borders with
Chile, Bolivia, Paraguay and Brazil22. Genomes from bacteria
isolated in 1991 and 1992 from Chile, Bolivia and Brazil were
included in our phylogeny7,9 (Fig. 3a). These were either Ogawa
(Bolivia, n= 7; Brazil, n= 1) or Inaba (N165fs; Brazil, n= 6;
Chile, n= 1) serotype. We found that these were interspersed
amongst contemporaneous serotype Ogawa isolates, which were
collected in Northern provinces of Argentina (Fig. 3a). All of
these isolates were members of cluster 4, except for one Bolivian
genome (1992) which was a member of cluster 2 (Fig. 3a). This
observation, and the lack of genetic diversity within LAT-1, are
consistent with the same V. cholerae sub-lineage circulating
within, and between, countries at the Northern border of
Argentina.
In 1996, cholera cases resurged in Argentina17 following a



























































































































Fig. 3 A phylogeny of the LAT-1 sub-lineage. a A maximum-likelihood phylogeny was calculated from 2,651 non-recombinant SNVs determined relative to
the A1552 reference sequence (see Methods). The tree is rooted on the sequence of CNRVC980048, an isolate lacking WASA-1 from Burkina Faso, 1984.
Scale bar denotes the number of mutations per variable site. Clusters were defined using Fastbaps using an alignment of 725 parsimony-informative SNVs.
Metadata are reported where available; gaps are presented where data were unavailable, not determined, or recorded as no data. Initial figure produced
using iCANDY and re-coloured manually (Adobe Illustrator CC). b Density plot illustrating the number of SNVs separating each of the LAT-1 isolates from
the A1552 reference sequence. The blue line indicates the mean (26.05 SNVs). Interactive phylogeny available in Microreact (https://microreact.org/
project/VAZD_K0kZ).
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V. cholerae (Fig. 1c). We found that 17 Argentinian Inaba
V. cholerae isolates from 1996 formed a closely-related subclade
within cluster 4 of the LAT-1 phylogeny (Fig. 3a), and harbour a
unique mutation in wbeT, Q274trunc. This clade includes one
2010 Inaba isolate from Mexico (Fig. 3a; Supplementary Figs. 7
and 8). In addition, this subclade shares a common ancestor with
the clade of isolates from 1997 which are serotype Ogawa and
form a separate phylogenetic cluster (cluster 1, 48 isolates, Fig. 3a;
Supplementary Figs. 7, 8). The 1996/1997 outbreak was not
geographically-restricted; isolates from multiple provinces were
part of this cluster (Fig. 3a).
Non-7PET diversity contrasts with LAT-1 clonality. Sixty-five
isolates sequenced in this study were not members of 7PET, but
were obtained from the same regions and times as the LAT-1
isolates (Figs. 1d, 4a, b; Supplementary Data 3). Thus, we placed
these into context with a more diverse collection of V. cholerae
sequences7, together with genomes from a recently-published
study of non-epidemic V. cholerae O1 in China48, and then cal-
culated a pangenome using these sequences (Fig. 4). The rate of
gene discovery as sequences were added to the non-7PET pan-
genome was much greater than was observed in a LAT-1
pangenome, despite there being 38% more isolates in the LAT-1
pangenome (Fig. 4c, d). This indicates that genes are not being
gained or lost by LAT-1. The non-7PET isolates were also
extremely genetically diverse in comparison to the 7PET gen-
omes, with a mean average nucleotide identity (ANI) relative to
A1552 of 97.61 (min 95.90, max 99.65, stdev 0.960; Fig. 4e), in
contrast to LAT-1 (mean ANI 99.99, min 99.96, max 99.998,
stdev 0.0032; Fig. 4e). An ANI value of 95% is a common
threshold for separating species49. The non-7PET isolates had a
considerably expanded accessory genome when compared to
LAT-1 (23,458 cloud genes in the collection of 383 diverse gen-
omes compared to 3,313 in the 532 LAT-1 genomes) (Supple-
mentary Fig. 6).
Of these 65 isolates, four were phenotypically and genotypically
serogroup O1. Two were members of the previously-described
Gulf Coast lineage of V. cholerae O1, including the single
sequenced V. cholerae O1 from 1998. Both Gulf Coast isolates
harboured CTX and were toxigenic, and the two remaining
V. cholerae O1 isolates were members of ELA-3 (ref. 7)
(Supplementary Fig. 10a; Supplementary Data 3). All four isolates
were of clinical origin (Supplementary Data 3). The remaining 61
isolates lacked the genes required to produce cholera toxin, and
were confirmed in silico not to harbour genes encoding the O1
antigen, though 45 of these were of clinical origin. We identified
four new lineages of non-O1 non-7PET V. cholerae amongst
these isolates, defined as clades formed by three or more
Argentinian non-7PET isolates in the phylogeny, and denoted
as A1–A4, where A stands for ‘Argentina’ (Fig. 4f). These lineages
contained isolates that were of clinical origin alone (A1, A3) or
clinical and environmental origin (A2, A4), were acquired in
different years (A3, A4), and from different regions (A2, A3, A4),
suggesting that these represent populations of non-7PET V.
cholerae local to Argentina (Fig. 4f, Supplementary Data 3).
Of the 61 non-O1 non-7PET isolates, 21 harboured one of
three distinct Type III secretion systems (Fig. 4f; Supplementary
Data 3). These included the T3SS-2α described in V. cholerae
AM_19226 (refs. 50,51), the less-common T3SS-2β system
described by Carpenter et al.51, and a third putative T3SS system
which most closely resembles genes present in the genomes of
two virulent Chilean Vibrio anguillarum isolates52 (Supplemen-
tary Fig. 10). This putative T3SS was found in lineage A2. The
presence of T3SS-2β in lineage A3 is of particular interest — this
lineage is composed of clinical isolates, contains the previously-
described Argentinian isolate TUC_T2734 (ref. 7), and includes
one isolate from Salta province in the year 2000. T3SS elements
were mutually exclusive and were never detected in the same
genome at the same time (the distribution of T3SS is described in
Supplementary Fig. 10 and Supplementary Data 3). From these
limited data it is clear that more T3SS-positive non-7PET were of
clinical origin than environmental (T3SS-2α: 10 clinical, 2
environmental; T3SS-2β: 5 clinical, 0 environmental; V. angu-
illarum element; 1 clinical, 3 environmental). It is also important
to note that none of these T3SS are present in 7PET.
Discussion
We contend that the observations described here could only have
been made in Latin America and in Argentina. This is because the
limited introductions of 7PET sub-lineages into the region, and
the consequentially-enhanced surveillance schemes, provided a
unique opportunity to understand the long-term evolutionary
dynamics of epidemic V. cholerae evolving from point-source
introductions on a continent where there have been millions of
cholera cases from 1991 to present. This is the largest genomic
study to date that investigates pandemic cholera in a single
country, and we believe that it is the largest sequencing project
designed to investigate the genomics of a single bacterial patho-
gen in Argentina. These data have had direct impact on national
health policies in Argentina by changing the national alert system
to distinguish between pandemic 7PET lineage and local V.
cholerae using whole-genome sequencing. This recognises the
increased risk presented by an outbreak of 7PET relative to that of
a non-7PET outbreak, even if toxigenic or serogroup O1. This is
to ensure that an epidemic response focuses on high-risk 7PET
clones, and that there is also efficient monitoring of the con-
tributions of endemic non-7PET clones to public health,
including via environmental surveillance using a One Health
approach.
Our data show that Ogawa V. cholerae from Argentina in 1992
are closely related to the Inaba isolates sequenced from Peru
(Fig. 3a), and show that the Inaba/Ogawa shift observed in Peru
and elsewhere in Latin America represented variation within
LAT-1, rather than a separate introduction of another strain
(Fig. 3a; Supplementary Fig. 8). Likewise, the outbreak of Inaba V.
cholerae in Argentina in 1996 arose by mutation of wbeT from
wild-type to an Inaba genotype (Q274trunc), and this mutation
may have occurred in Argentina. The Q274trunc mutation is
distinct from others identified within the data set, particularly the
mutation associated with the Inaba phenotype in con-
temporaneous Mexican isolates (N165fs). This indicated that
Argentinian cholera in 1996 was not caused by an introduction of
a new Inaba (sub)lineage from elsewhere in Latin America;
rather, LAT-1 V. cholerae that had already been introduced into
Northern Argentina or the neighbouring countries acquired a
new Inaba genotype and phenotype. The 1997 Argentinian out-
break, in turn, was caused by a close relative of the 1996 Inaba
clone, but the topology of our phylogeny suggests that this was
not a result of reversion from the Inaba Q274trunc genotype to
an Ogawa genotype (Fig. 3a), adding nuance that would have
been useful for public health at the time of the epidemic. These
data underline that Ogawa/Inaba phenotypic variation is not
phylogenetically informative, and may not be appropriate to use
as an epidemiological marker.
Perhaps surprisingly, in spite of the sustained circulation of
LAT-1, which was disseminated across Northern Argentina, an
area of ~1.2 million km2 (Fig. 1b, Supplementary Fig. 4), these
data suggest that very little genetic change, at the level of SNVs
and gene gain/loss, occurred in this sub-lineage over a period of
nearly 6 years. This lack of diversity is reminiscent of the clonality
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in other bacterial pathogens, such as Salmonella Typhi
H58 (ref. 53). Our data also show that LAT-1 circulated amongst
the countries at the Northern borders of Argentina during the
early 1990s— for instance, cholera was first reported in Bolivia in
August 1991 (refs. 5,54), and Bolivian genomes from the early
1990s are intermixed amongst the Argentinian genomes from
1992 (Fig. 3a; Microreact). The lack of clustering by region is
likely to reflect the rapid dissemination of LAT-1 across South
America.
LAT-1 invariance is juxtaposed with the diversity observed in
non-O1 V. cholerae in Argentina (Figs. 3 and 4; Supplementary
Fig. 6). Although V. cholerae research has tended to focus on
studying epidemics and outbreaks, by definition, this tends to
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variable, and as well as examples of local lineages of non-7PET V.
cholerae, we also identified isolates which were confirmed
microbiologically to be Vibrio cholerae, but were diverse phylo-
genetically and as measured by ANI values. Non-7PET V. cho-
lerae continue to be associated with clinical cases of disease, but
remain understudied. The disease associated with these iso-
lates — and whether virulence determinants such as T3SS con-
tribute to this disease — is the focus of future work, though there
is evidence to suggest that T3SS contributes to diarrhoea caused
by non-7PET V. cholerae55. We also see here, with the caveat of a
small sample size, that the clinical non-7PET isolates were enri-
ched for the presence of T3SS (16/21 isolates).
We show that a single clone of V. cholerae O1 (Fig. 2), now
known to be one sub-lineage of 7PET7, was responsible for
pandemic cholera in Argentina2,3,25,56, in spite of the seasonal
fluctuations and serotype variation observed (Fig. 1c). Our
genomic data provide fine-scaled insight into the evolution of
LAT-1 that would not have been captured by routine surveillance
alone. However, it is also important to state that these data
validate fundamental observations made by public health
authorities during the cholera epidemics of the 1990s — that the
outbreaks in Argentina were caused principally by Ogawa
V. cholerae, which were closely related to the Peruvian strain as
determined by PFGE1,25,47,57,58. Furthermore, by including non-
7PET V. cholerae in our study, we found a highly diverse popu-
lation of this species in Argentina existing concurrently with the
extremely invariant LAT-1 pandemic sub-lineage. We suggest
that these non-7PET, which include O1 and non-O1 serogroup
isolates, represent those V. cholerae that are truly endemic to
Argentina, and are evolving locally but lack the propensity to
cause epidemics and to spread in the same way as 7PET.
Therefore, the fact that Latin America was cholera-free for 97
years was due solely to the absence of pandemic lineages, and it is
a consequence of elevated surveillance due to the LAT-1 intro-
duction that endemic V. cholerae were captured. In the absence of
clinical data associated with these non-7PET isolates, we cannot
determine whether they are aetiological agents of cholera, or of a
cholera-like illness. However, it is clear that non-7PET V. cholerae
were present, and associated with disease at a low level, in
Argentina throughout the 1992–1998 cholera epidemic and
thereafter (Fig. 1c).
It is vital to understand the diversity of the local, endemic V.
cholerae that co-exist alongside 7PET during a cholera epidemic.
This is because non-epidemic V. cholerae present in a country
may contribute to cases of disease that are symptomatic of cho-
lera, but do not pose the same relative risk to public health as
7PET. The case in the Chaco region during 2005, which was
caused by non-epidemic V. cholerae O1 of the MX-2 lineage7 and
failed to cause epidemic cholera, exemplifies this point. Similar
observations have recently been made in China48. Relative risk of
V. cholerae lineages should be accounted for in the magnitude of
epidemic preparedness responses to such outbreaks, as is now
being done in Argentina. The Global Task Force on Cholera
Control has committed to reducing deaths from cholera by 90%
before the year 2030 (ref. 59). This campaign focuses on the
control of cholera, the disease, rather than on 7PET, the aetio-
logical agent of epidemic cholera. As cholera control is imple-
mented in countries that currently experience a high incidence of
cholera attributed to 7PET, cases of cholera will decline. We
anticipate that as epidemic cholera is reduced in magnitude,
disease caused by non-7PET V. cholerae will become more visible,
just as has been observed in Argentina. By using genomic defi-
nitions to differentiate pandemic lineages for public health epi-
demic preparedness responses, as is being done in Argentina, we
propose that concerted control efforts including epidemiologists,
public health authorities and microbiology laboratories targeting
7PET specifically, and accounting for background levels of
endemic non-7PET disease, could see epidemic cholera elimi-
nated in Latin America.
Methods
Bacterial strains and oligonucleotide primers. A list of bacterial isolates
sequenced in this study is reported in Supplementary Data 1–3, together with
relevant metadata and results from genomic analyses. Additional genome
sequences used for contextualisation are listed in Supplementary Data 1–3. The
sequences of oligonucleotides used for PCR (see Microbiology section below and
Supplementary Methods) are detailed in Supplementary Table 1.
Bacterial culture, genomic DNA isolation and sequencing. Vibrio cholerae
isolates were revived from archived stocks on tryptic soy agar plates or in alkaline
peptone water, and were subsequently passaged on thiosulfate-citrate-bile salts
media to select for V. cholerae. Minimal biochemical tests (oxidase, Kligler tests)
were performed to confirm Vibrio spp. identity. Genomic DNA extractions at INEI
were carried out from 1ml of liquid culture using the QiaCube Connect (Qiagen).
Extractions carried out at the Sanger Institute were performed using the Epicentre
Masterpure kit and a modified version of the manufacturer’s protocol60 — briefly,
single purified colonies of V. cholerae were used to lawn an LB agar plate. Loopfuls
of bacterial lawns were resuspended in 300 μl Tissue & Cell Lysis Solution sup-
plemented with Proteinase K, incubated at 65 °C for 20–25 min with intermittent
vortexing to lyse cells, and then treated with RNase A for 30 min to remove
contaminating RNA. Thereafter, the manufacturer’s protocol was followed to
remove protein contaminants and to purify genomic DNA. Approximately 0.5 μg
of genomic DNA per isolate was used for sequencing with the Illumina HiSeq X10
platform at the Wellcome Sanger Institute.
Microbiology. Isolates were received and subjected to biochemical and molecular
testing by INEI at the time of their receipt, principally during the 1992–1998
epidemic period. During the cholera epidemic, minimal biochemical tests (Kligler,
oxidase, haemaaglutination and indole) and complementary tests (chloride and
decarboxylase) were performed to verify the identity of V. cholerae. The production
of cholera toxin was assessed using enzyme-linked immunosorbent (ELISA)
assays61. Where required, PCR was performed to confirm an isolate as V. cholerae,
as well as the presence of genes encoding ctxA and tcpA62, and other virulence
factors. The oligonucleotide primer sequences and reaction conditions for these
PCR tests are detailed in Supplementary Methods and Supplementary Tables 1–5.
All of the microbiological and molecular assays used at INEI-ANLIS for the
characterisation of V. cholerae are also described in a publicly-accessible protocol
manual63.
Sequence data quality control. A total of 21 sequenced isolates contained sub-
stantial amounts of contaminating sequences from non-Vibrio species, and
were excluded from this study, for a total of 490 sequences used in this analysis.
Contamination was assessed using Kraken64, by examining the overall length
of the SPAdes assembly (data were summarised using assembly-stats v1.0.1
Fig. 4 Contrasting the diversity of 7PET and non-7PET V. cholerae from Argentina.Maps depicting the year and place of origin of the isolates sequenced
in this study are presented for 7PET and non-7PET isolates in (a) and (b), respectively. The non-7PET isolates were obtained from the same regions and
years as the 7PET isolates. The number of new and unique genes added to the 7PET (LAT-1) pangenome and the non-7PET pangenomes are depicted in (c)
and (d), respectively. The ANI for 7PET (both LAT-1 and F99/W) and non-7PET genomes sequenced in this study against the A1552 reference sequence
are presented as a boxplot in (e). f Depicts a maximum-likelihood phylogeny calculated using 201,790 SNVs from a core-gene alignment of 2719 genes
from 380 V. cholerae sequences, plus an outgroup of three related Vibrio species (383 sequences in total, Supplementary Data 3) on which the tree is
rooted (brown). Lineages are named in line with previous reports7. Blue circles denote non-7PET lineages A1–A4. Scale bar denotes the number of
mutations per variable site. e Boxplot details: Centre line=median, hinges= upper and lower quartiles, whiskers= 1.5 *interquartile range, outliers are
plotted as datapoints.
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(https://github.com/sanger-pathogens/assembly-stats) and assemblies greater than
5Mbp in length were excluded) and by inspection of initial phylogenetic trees.
Genome assembly and annotation. Illumina sequencing reads were assembled
using SPAdes v3.8.2 (ref. 65) as part of a high-throughput analysis pipeline66, and
annotated using Prokka v1.5 (ref. 67). External publicly-available sequences were
similarly assembled from raw sequencing reads — where these were not available,
assemblies were downloaded from Genbank and annotated using Prokka v1.5 for
uniformity within the data set.
Pangenome analysis. Pangenomes were calculated using annotated genome
sequences for a diverse collection of V. cholerae (Supplementary Data 3) as well as
the LAT-1 subset of a 7PET-specific data set (Supplementary Data 2). Roary
v3.12.0 (ref. 68) was used for these calculations, with options ‘-e–mafft -s -cd 97′.
For the non-7PET genome collection, an alignment of 2719 core genes was used for
phylogenetic analysis (see below).
SNV identification and phylogenetic analysis. For 7PET and LAT-1 phyloge-
netic analyses, sequencing reads were mapped to reference genomes (accession
numbers LT907989/LT907990 for N16961; CP025936/CP025937 for A1552) using
SMALT v0.7.4 (http://www.sanger.ac.uk/science/tools/smalt-0). The reference was
indexed using SMALT using a kmer size of 20 and a step size of 13 (-k 20 -s 13),
and the reads were aligned using default parameters but with the maximum insert
size (i) set as three times the mean fragment size of the sequencing library (target
insert size 450 bp). PCR duplicate reads were identified using Picard v1.92 (https://
broadinstitute.github.io/picard/) and flagged as duplicates in the BAM file. High-
quality single nucleotide polymorphisms, including small indels, were identified as
described by Harris et al.69 and reported previously for V. cholerae7,28. Briefly, BCF
files of all variant sites were generated using samtools mpileup v0.1.19 (ref. 70)
(parameters -d 1000 -DSugBf) and bcftools v0.1.19 (http://samtools.github.io/
bcftools/). The bcftools option to call genotypes at variant sites was used. The
following bcftools cut-off thresholds were applied: quality <50, map_quality <30,
af1 < 0.95, ratio <0.75, depth <4, depth_strand <2, strand_bias <0.001, map_bias
<0.001 and tail_bias <0.001. If any of these filters were not met, the base was
called as uncertain. A pseudo-genome was constructed by substituting the base
call at each site (variant and non-variant) in the BCF file into the reference
genome. Uncertain sites were substituted with an N. Insertions with respect to
the reference genome were ignored and deletions with respect to the reference
genome were filled with N’s in the pseudo-genome to keep it aligned and the same
length as the reference genome.
Regions of the genome which were predicted to be recombined, and which
might therefore affect the topology of calculated phylogenies, were identified and
removed from the pseudogenome alignment using Gubbins v1.4.10 (ref. 71).
Alignments consisting entirely of variable nucleotides were produced from whole-
genome alignments using SNP-sites v2.4.1 (ref. 72). The non-7PET core-gene
alignment was trimmed using trimAl v1.4.1 (ref. 73), and SNP-sites v2.5.1 was used
to produce an alignment of 201,790 variable nucleotides. Maximum-likelihood
phylogenetic trees were then calculated from SNV-only alignments using IQ-Tree
v1.6.10 (ref. 74) under the general time reversible (GTR) and ascertainment bias
correction (ASC) models75. Five thousand approximate likelihood ratio tests76 and
ultrafast bootstrap approximations77 were performed to assess the robustness of
the computed phylogenies.
LAT-1 genomes were clustered using Bayesian hierarchical clustering and
partitioned using the Dirichlet Process Mixture model with Fastbaps v1.0.1 (ref. 31),
run using default parameters. Fastbaps was similarly used to cluster sequences in
the V. cholerae species phylogeny, using the Bayesian Hierarchical Clustering
prior78 and excluding the three outgroup sequences from the alignment.
Parsimony-informative SNVs were extracted from SNV-only alignments using
extract_PI_SNPs.py (https://gist.github.com/jasonsahl/9306cd014b63cae12154)
and these alignments were used as the input for Fastbaps. SNV distance matrices
were calculated from SNV-only alignments using snp-dists v0.4 (https://github.
com/tseemann/snp-dists). Average nucleotide identity (ANI) values were
calculated using FastANI v1.0 (ref. 49).
Detection of plasmid replicons, antimicrobial resistance genes, ctxB variants
and in silico serotype assignment. wbeT and ctxB genotypes were assigned using
ARIBA v2.12.1 (ref. 79) and a custom database consisting of the ctxB nucleotide
sequence from N16961 (LT907989/LT907990) and the intact wbeT sequence from
NCTC 9420 (ref. 80) (CP013319/CP013320), which translates into a protein
sequence which is 100% identical to the WbeT sequence from the Ogawa isolate
VX44945 (AEN80191.1)81. We assumed that an Inaba phenotype would be con-
ferred on isolates in which ARIBA79 was unable to detect or assemble wbeT in its
totality, and if a mutation in wbeT was detected that was predicted to frameshift or
truncate translated wbeT (N62fs, N165fs, F244fs, Q274trunc), was associated with
Inaba phenotypes (I206K), or was otherwise known to confer an Inaba phenotype
(S158P82). We assumed, since none of the isolates harbouring the E36D wbeT
mutation had an Inaba phenotype, that this mutation does not result in abolition of
an Ogawa serotype. The sequences of other virulence genes were taken from the
sequence of N16961 (LT907989/LT907990) or of the Classical V. cholerae isolate
O395 (CP000626/CP000627). We confirmed using BLASTn and the pangenome
gene presence/absence matrix that the WASA-1 genomic island, a marker char-
acteristic of the LAT-1 sub-lineage9,32, was present in the assemblies for these
sequences. Plasmid replicons and antimicrobial resistance genes were detected
using ARIBA, the ResFinder database83, and the PlasmidFinder database84 (both
databases accessed on 23/06/2019). The presence and absence of the V. cholerae
serogroup O1 biosynthesis operon in non-7PET genomes was confirmed using the
pangenome gene presence/absence matrix, and by testing for the presence of the
O1 biosynthesis operon sequence using BLASTn (co-ordinates 234,000–286,000 in
the N16961 reference genome, accession LT907989).
Data visualisation. Data were visualised and maps were annotated using
Tableau Desktop 2018.31. Maps in Tableau were produced using OpenStreetMap
(© OpenStreetMap contributors) which is licenced under a CC-BY-SA licence
(https://www.openstreetmap.org/copyright). Phylogenetic trees were visualised
using Figtree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/) and iTOL v3 (ref. 85).
Gene presence/absence matrices were visualised using roary_plots.py v0.1.0
(https://github.com/sanger-pathogens/Roary/tree/master/contrib/roary_plots).
Other figures were produced using R v3.5.1 with the ggplot2 v3.1.1 (ref. 86) and
reshape v0.8.8 (ref. 87) packages, Artemis v16 (ref. 88), ACT v13 (ref. 89), DNA-
plotter v1.11 (ref. 90), the Phandango web server91, Easyfig v2.2.2 (ref. 92), and
iCANDY (https://github.com/simonrharris/iCANDY). Where figures were edited
manually, this was performed using Adobe Illustrator CC v23.0.4.
Ethics. Not applicable. This study uses archived bacterial samples processed by
INEI. No identifiable data were available or used in this study.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
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